Multiple Advantages of α-Fetoprotein as a Marker for in Vivo Gene Transfer

This publication has 50 references indexed in Scilit:

• High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels ofα₁-Antitrypsin with Negligible Toxicity
  Human Gene Therapy, 1998
• Immune Responses to Reporter Proteins and High Viral Dose Limit Duration of Expression with Adenoviral Vectors: Comparison of E2a Wild Type and E2a Deleted Vectors
  Human Gene Therapy, 1997
• Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors
  Nature Medicine, 1996
• Gene therapy for ornithine transcarbamylase deficiency
  Pediatrics International, 1996
• High Level Expression of Human α-Fetoprotein in Transgenic Mice
  Biochemical and Biophysical Research Communications, 1993
• Efficient selection for high-expression transfectants with a novel eukaryotic vector
  Gene, 1991
• Expression of human α-fetoprotein in yeast
  Life Sciences, 1990
• Primary structures of human alpha-fetoprotein and its mRNA.
  Proceedings of the National Academy of Sciences, 1983
• Alpha-Fetoprotein: A Review
  CRC Critical Reviews in Clinical Laboratory Sciences, 1981
• Expression of a Bacterial Gene in Mammalian Cells
  Science, 1980